274
·
2025-12-25
$ProShares UltraPro S&P500 ETF(UPRO)$ If you can’t handle $ProShares UltraPro QQQ(TQQQ)$ , you can totally consider allocating to this 3× S&P ETF. Compared to its 2020 low, it has already risen 10× over the past four years and has broken through its all-time high, making it very attractive to buy.
331
·
2025-12-25
$Broadcom(AVGO)$ The AI boom shows no signs of cooling, and global semiconductor sales are expected to grow 30% year-on-year next year, surpassing $1 trillion for the first time. Still bullish on companies like NVIDIA and Broadcom.
351
·
2025-12-25
$Qifu Technology(QFIN)$ The fintech lending market has a scale of hundreds of billions, offering plenty of room. With a leading position, healthy financials, dividends plus buybacks and cancellations, and a reasonable valuation, it’s entering the sweet spot. For a company like this, making money isn’t the problem — the key is “surviving long enough” and “the last one standing wins.” Success depends on a combination of risk management, strategic insight, and technological iteration, underpinned by culture and talent.
248
·
2025-12-25
$SanDisk Corp.(SNDK)$ Tech stocks have been absolutely on fire lately, especially the memory space. Micron is already up over 240% YTD and still pushing higher, while Sandisk and Western Digital are just crazy — up several times this year. You can’t argue with a trend like this. Riding the core theme and watching profits stack up feels amazing.
202
·
2025-12-25
$CG Oncology Inc.(CGON)$ has been climbing steadily this round ! With the precious metals rally driving the gold miner sector higher, it feels like I nailed the timing .
288
·
2025-12-25
$Direxion Daily Financial Bull 3x Shares(FAS)$ is on a roll! 1.73% gain on Christmas rally plus $0.3874 per share dividend – double wins are amazing!
284
·
2025-12-25
$ProShares Ultra Silver(AGQ)$ Looking back at the 10-year cycle of precious metals, it’s pretty clear that silver is still massively undervalued compared to gold . Gold has already run hard this cycle, but silver still has a lot of upside left — and once the catch-up move really kicks in, the leverage can be huge .
254
·
2025-12-25
$Micron Technology(MU)$ ramping up its FY2026 capex to $20 billion, adding another $2 billion and speeding up equipment orders and installations — basically pushing hard to etch more chips, faster . Cleanroom plays have already taken off, and the logic is getting clearer by the day.
1.77K
·
2025-12-25
🐶 Options Puppy Daily Strategy How I Consistently Scrap $10–$30 a Day Using PLTR & IWM Cash-Secured Puts — and Why Both Can Do Well Into 2026
I call myself an Options Puppy 🐾. Not because I’m small-minded, but because I respect the market, stay curious, and focus on survival first. Puppies don’t try to outrun wolves on day one — they learn, observe, and grow stronger through repetition. My trading strategy is built on this mindset. I don’t chase home runs. I don’t predict tops or bottoms. Instead, I sell time, control risk, and aim to consistently scrap $10–$30 a day using cash-secured puts on PLTR and IWM. This article explains: • My exact daily mindset • The math behind the strategy • Why $10–$30 a day is powerful • Why PLTR and IWM are ideal option-selling vehicles • And why both still make sense heading into 2026 📆 ⸻ 🧠 The Options Puppy Philosophy: Survive First, Scale Later Most traders fail not because they lack intelligen
TOPBtWin: I believe you have a patient to wait when it assign far deep in the money. if it drop further 5 to 10% after get assigned that's even requirement 10x patient s it seems s $1k losses for weekly $10 to 20 it take more than a year to recover back.
17.02K
·
2025-12-25
2025 Recap | Top 10 Investment Topics of 2025
2025 came to a close with global markets swinging between political shocks and technological breakthroughs.Trump’s return reignited policy uncertainty, AI competition reshaped capital allocation, gold rewrote history, and megacaps expanded the limits of imagination.Markets trembled under tariff threats — yet celebrated amid an unprecedented computing boom.Let’s look back at the Top 10 Investment Topics of 2025.1. Trump Returns: Global Tariff Turmoil & “TACO Trades”Trump officially returned to the White House, pushing markets into a new phase of policy-driven repricing, with tariffs, fiscal stimulus, and geopolitical uncertainty back.2. SPX Hits Record Highs for 39th Time$S&P 500(.SPX)$ is on pace for a solid year of record closing highs. A
TOPFor me, 2025 is best defined by the AI-driven shift in capital allocation, highlighted by Nvidia surpassing $5 trillion. It wasn’t just about one stock, but about markets recognizing compute power as core infrastructure. Even with tariffs, geopolitics, and policy noise, money consistently flowed toward AI enablers. The most valuable lesson came from managing volatility rather than chasing returns. With constant headline shocks — from Trump tariffs to China’s AI breakthroughs and crypto swings — reacting emotionally often hurt performance. Focusing on market structure, liquidity, and defined risk mattered far more than predicting news. Ultimately, 2025 showed that markets now price narratives as much as fundamentals. AI, geopolitics, and digital assets blended into a powerful expectation engine. As we move into 2026, uncertainty remains high, but so does imagination — and that balance defines the year for me. @TigerStars @Tiger_comments @TigerClub
1.49K
·
2025-12-25
Option Movers | Nike's $60 Call Soars 1067%; Philip Morris Sees 100% Call Options
Market OverviewThe S&P 500 and the Dow Jones Industrial Average ended at record closing highs on Wednesday (Dec. 24), while gold held just below the $4,500 mark by the conclusion of a light-volume, truncated Christmas Eve session.Regarding the options market, a total volume of 27,842,425 contracts was traded, down 35% from the previous trading day.Top 10 Option VolumesTop 10: $TSLA(TSLA)$, $NVDA(NVDA)$, $MSTR(MSTR)$, $AAPL(AAPL)$, $NKE(NKE)$, $NFLX(NFLX)$, $MU(MU)$,
TOP$Smart NZ Property ETF Units(NPF.NZ)$ ahha
1.23K
·
2025-12-24
Rocket Lab's Neutron Revolution: Ready to Eclipse SpaceX or Just Shooting for the Stars? 🚀🌌
$Tesla Motors(TSLA)$ Rocket Lab is firing on all cylinders, carving out a niche as SpaceX's nimble rival with relentless launch cadence and bold expansions that have investors buzzing. 😎 As of December 24, 2025, RKLB shares hit $25.74, up 10% in a single session after clinching an $816 million satellite deal with the U.S. Space Development Agency, pushing its backlog to $1.2 billion and cementing its role in defense space tech. The company's Electron rocket has nailed 20 successful launches this year, a record that outpaces expectations and positions it as a go-to for small-payload missions amid surging demand from satellites and constellations. But the real game-changer looms: the reusable Neutron rocket, now delayed to 2026 for final tweaks, pro
TOPThink you ment rklb hit $75.74 per share not $25.74.
1.14K
·
2025-12-24
ARK Cashes In on Tesla's Peak Surge – Dump Now or Hold for 2026 Robotaxi Riches? 😲🚀
$Tesla Motors(TSLA)$ $ARK Innovation ETF(ARKK)$ Cathie Wood's ARK funds just trimmed 60,715 Tesla shares worth $29.67 million right after the EV giant hit fresh highs, sparking debates on whether this is smart profit-taking or a miss on the massive upside ahead. With Tesla closing at $485.56 on December 24, 2025, down 0.65% from the prior day but still up 12% YTD, the move comes as analysts dial back Q4 delivery expectations amid fading incentives. Yet, the stock's technical buy zone holds strong, with RSI resetting to 58 and volume booming 30% on rebound hopes – this dip could be the perfect entry before Optimus ramps unlock $200B rev by 2027. Emerging markets add spice, with China's 10% sales rebound bo
1.19K
·
2025-12-24
S&P Smashes Records on Tech Surge & Gold Boom – Hunt These Stocks Before Holiday Shutdown Hits! 🚀🪙
Wall Street capped a wild week with the S&P 500 posting its third-straight winning day, climbing 0.6% to 6,878.49 on soft inflation data that cooled yields to 3.75% and locked Fed cuts at 87% odds – this soft print unleashes risk-on vibes for a potential Santa squeeze to 7,100 if PCE Thursday cools below 2.3%. Tech gains dominated, with Micron rising 10% to $115 on blowout earnings from booming AI market, memory demand tripling from Nvidia's H200 frenzy – Q1 rev $9.05B up 18% crushes, unlocking $130 highs as semis rebound from last week's wreck. Tesla jumped about 1% to $446.74, riding $3T valuation buzz on Optimus ramps and FSD v14 boosting ARPU 10%, while Nvidia surged 3% to $140.50 on open-source AI models adding $5B ecosystem rev by 2027. Broadcom gained over 2% to $159.10 on inter
TOPTech surge is insane! Grabbed MU dips for quick flip.[得意]
573
·
2025-12-24
Genting’s "Valley of Death" Warning (SGX Daily Stock Review 24 Dec)🦖 EP1338
🟩 Is your portfolio ready for the "Strategic Divergence" coming in 2026? While the markets are quiet for the holidays, massive moves are happening under the hood that could redefine your dividend income next year. A surprising beat in US GDP—hitting 4.3% against expectations—is threatening to keep interest rates "Higher for Longer," putting immediate pressure on Singapore REITs and mortgage holders just as we head into the new year. In this special Christmas Eve breakdown, we unwrap three critical stories reshaping the SGX landscape. We analyze Sembcorp’s bold but debt-heavy acquisition in Australia, dissect why City Developments Limited (CDL) suddenly popped 6% in a sleepy market, and expose the "Valley of Death" cash flow trap facing Genting Singapore. Plus, we reveal why major analysts
TOPSolid insights! Keen to see how Genting navigates this.[开心]
860
·
2025-12-24
From my perspective, confirmation that NVIDIA plans to resume H200 deliveries to China around mid-February 2026 is a meaningful near-term catalyst. The expected 5,000–10,000 module sets—equivalent to roughly 40,000–80,000 H200 chips—won't redefine NVIDIA's global revenue base on their own, but they clearly help stabilize expectations around China exposure. After months of uncertainty driven by export controls, even partial normalization reduces downside risk and improves visibility, which explains why the stock reacted positively with a 3% gain. That said, I see the China H200 story more as a confidence booster than a structural growth re-acceleration. The volume involved is material, but not transformative compared with hyperscaler demand in the US, Middle East, and Europe. What matters m
1.17K
·
2025-12-24
From my perspective, the approval of oral Wegovy is the most important positive catalyst Novo Nordisk has seen this year. A pill form fundamentally lowers the barrier to adoption versus injections, especially for primary care patients and long-term weight management. The market's 7% reaction makes sense to me, because this isn't just a line extension—it meaningfully expands the addressable market and strengthens Novo's positioning in the obesity franchise. That said, I also understand why NVO is still down 38% year to date while Eli Lilly keeps making new highs. Lilly has clearly won the narrative this year, with faster innovation cycles, stronger momentum in data readouts, and more consistent execution. Novo's drawdown reflects disappointment rather than collapse—its core GLP-1 economics
TOPNice Sharing 😊 I prefer Eli Lilly 😄 @JC888 @Barcode @Aqa @DiAngel @koolgal @Shernice軒嬣 2000
273
·
2025-12-24
1. China H200 ship-ups and catalyst potential Plans to begin delivering H200 AI chips to China around mid-February 2026 are now widely reported. Initial shipments are expected to comprise roughly 5,000–10,000 module sets, equivalent to approximately 40,000–80,000 chips, subject to Chinese regulatory approval. The move follows a reversal in U.S. export policy that permits H200 sales to “approved customers” with a 25% revenue share for the U.S. government. These shipments would mark the first major resumption of Nvidia’s AI chip exports to China after prior bans. From a demand perspective, the China market represents a meaningful addressable opportunity for Nvidia given the scale of AI adoption among hyperscalers and cloud providers there. Analysts estimate H200 sales could add materia
262
·
2025-12-24
Gold reaching USD 5,000 in 2026 is plausible, but not inevitable. Will gold hit USD 5,000 in 2026? The move towards USD 4,500 suggests gold is already pricing in a combination of policy easing, geopolitical risk and structural demand. Two Fed cuts in 2026 would lower real yields, which is historically supportive for gold. In addition, persistent central bank buying, fiscal deficits and currency debasement concerns provide a strong long-term floor. That said, USD 5,000 likely requires a reinforcing shock, such as a sharper economic slowdown, renewed inflationary pressure, or an escalation in geopolitical conflict. In a benign soft-landing scenario with stable growth and a firm US dollar, gold may consolidate between USD 4,200 and USD 4,700 rather than extend aggressively. How to express the
676
·
2025-12-24
Novo Nordisk’s rally on approval of an oral Wegovy is strategically important, but it does not automatically guarantee a sustained turnaround. Why the oral approval matters An effective oral GLP-1 materially expands the addressable market. Many patients avoid injectables due to inconvenience or needle aversion, particularly in primary care and early-stage obesity treatment. From a competitive standpoint, this is Novo Nordisk’s first credible answer to Eli Lilly’s strong pipeline momentum and helps rebalance the narrative that NVO is structurally losing ground. Why NVO underperformed so sharply NVO’s 38% decline this year reflects a mix of factors rather than a collapse in the obesity thesis. Concerns centred on manufacturing capacity, slower-than-expected supply expansion, pipeline disappo